• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Burzynski Research Institute Inc

+ Add to Watchlist


0.1510 USD 0.0010 0.67%

As of 20:10:00 ET on 09/18/2014.

Snapshot for Burzynski Research Institute Inc (BZYR)

Open: 0.1500 Day's Range: 0.1500 - 0.1510 Volume: 10,239
Previous Close: 0.1500 52wk Range: 0.0300 - 0.5000 1-Yr Rtn: +115.71%

Stock Chart for BZYR

No chart data available.
  • BZYR:US 0.1510
  • 1D
  • 1M
  • 1Y
Interactive BZYR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BZYR

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0400
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 19.85
Shares Outstanding (M) 131.45
30 Day Average Volume 6,079
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/15/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BZYR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BZYR

Burzynski Research Institute, Inc. manufactures medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids. The Company is conducting clinical trials of Antineoplastons relating to the treatment of cancer. Burzynski is seeking Food and Drug Administration approval for the sale of Antineoplastons.

Stanislaw R BurzynskiChairman/PresidentTomasz JanickiVP:Clinical Trials
Patryk P GoscianskiTreasurer/Secretary
More Company Profile & Key Executives for BZYR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
  • BZYR News

  • Industry News

Sponsored Links
sec ||= nil